“Clinical links with the University of Oxford gave us access to exceptional expertise. When we wanted to explore a new therapeutic approach, we were able to quickly consult with an expert team of oncologists and surgeons – the kind of input that is usually out of reach for a small company.”

Kevin Maskell, Co-Founder and CSO, Bioarchitech (2024)